Our aim is to bring in high quality genetic testing in a phased manner Sun Oct, 08 PerkinElmer Genetics, Inc., which provides a global genomic lab testing platform, will accelerate its high quality and affordable genomic services in India. This platform will complement newborn screening tests for genetic disorders and help address complex and rare inherited diseases. Dr. Madhuri Hegde, VP and Chief Scientific Officer for laboratory services of PerkinElmer’s Diagnostics business group, reveals more in an interaction Read More: https://www.expressbpd.com/healthcare/market/our-aim-is-to-bring-in-high-quality-genetic-testing-in-a-phased-manner/391741/ How is genome testing evolving in India? Genome testing has evolved significantly in the last two decades. Since early 1990s many of the hospitals in India had only cytogenetic labs. Even five years ago, labs in India only focused on certain diseases like thalassemia and Down syndrome. Now with more advanced technology, we are able to look at the entire genome at a reduced cost. There is a misconception
PerkinElmer Hosts Medical Genomics Seminars in India Thu Aug, 31 | New Delhi, Delhi, India PerkinElmer Health Sciences Pvt Ltd (PEHS), a screening and diagnostic laboratory of PerkinElmer, Inc. today announced that it has kicked off a series of seminars for neurologists, paediatricians and gynaecologists in Delhi, Mumbai, Hyderabad, Chennai and Mangalore, India. These events serve as an ideal platform for discussing PerkinElmer’s recently launched affordable gene panels, whole exome sequencing (WES) and whole genome sequencing (WGS) services using next generation sequencing and other complementary assays to address the broad range of genetic disorders. At the first conference, which took place in Delhi, Dr. Madhuri Hegde, Vice President and Chief Scientific Officer, PerkinElmer Diagnostic Laboratory Services, delivered a talk, ‘Simplifying Genomics: Transforming Complexity into Meaning’ to a group of clinicians. Starting her presentation, Dr. Hegde said, “A growing interest in personalized medicine calls for genome sequencing in clinical diagnostics, but major
PerkinElmer Launches Clinical Whole Genome Sequencing Services Thu Aug, 03| PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Genetics’ clinical genomics services. Through its integrated laboratories in the U.S., India and China, PerkinElmer offers a global genomic lab testing platform that performs screening and diagnostic testing, specializing in newborn screening and high throughput next generation sequencing for rare inherited diseases. PerkinElmer Genetics has two state-of-the-art CLIA-certified clinical laboratories based in Pittsburgh, PA and Branford, CT that process more than 500,000 samples a year. Their testing menus include newborn screening, biochemical profiling, 2nd tier molecular confirmatory testing, Sanger and NGS-based panels, and exome and genome sequencing. Today, PerkinElmer Genetics has launched affordable whole exome sequencing (WES) and whole genome sequencing (WGS) services. These services are also offered in combination with biochemical profiling targeted for rapid WES and WGS for genetic disease
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.